Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer

Adjuvant therapy for patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer (EBC) remains challenging. The prognostic significance of HER2-low positivity in these patients is not fully understood. In our retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Shikata, Shohei, Murata, Takeshi, Yoshida, Masayuki, Hashiguchi, Hiromi, Yoshii, Yukiko, Ogawa, Ayumi, Watase, Chikashi, Shiino, Sho, Sugino, Hirokazu, Jimbo, Kenjiro, Maeshima, Akiko, Iwamoto, Eriko, Takayama, Shin, Suto, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640570/
https://www.ncbi.nlm.nih.gov/pubmed/37952045
http://dx.doi.org/10.1038/s41598-023-47033-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640570/
https://www.ncbi.nlm.nih.gov/pubmed/37952045
http://dx.doi.org/10.1038/s41598-023-47033-8

Ejemplares similares